fludrocortisone
Showing 1 - 25 of 94
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Nov 13, 2023
Salt Wasting, Hydro-sodium Balance and Fludrocortisone
Completed
- Congenital Adrenal Hyperplasia (CAH)
-
Paris, FranceHôpital Robert Debré
Sep 15, 2022
COVID-19, ARDS Trial in Cairo (Fludrocortisone Acetate 0.1 MG)
Completed
- COVID-19
- ARDS
- Fludrocortisone Acetate 0.1 MG
-
Cairo, Abbasia, EgyptAin Shams University
Jul 9, 2022
Critical Illness Related Corticosteroids Insufficiency Trial in Garches (Investigational products administration, Placebo
Recruiting
- Critical Illness Related Corticosteroids Insufficiency
- Investigational products administration
- Placebo administration
-
Garches, FranceGeneral Intensive care Unit, Raymond Poincaré Hospital, APHP
Feb 9, 2022
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Oct 23, 2023
Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)
Active, not recruiting
- Congenital Adrenal Hyperplasia (CAH)
- Flutamide
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Septic Shock Trial in Rennes (Fludrocortisone, Placebo)
Not yet recruiting
- Septic Shock
- Fludrocortisone
- Placebo
-
Rennes, Bretagne, FranceRennes University Hospital - Intensive Care unit
Aug 3, 2021
Neurogenic Orthostatic Hypotension Trial in Paris (Fludrocortisone, Placebo)
Recruiting
- Neurogenic Orthostatic Hypotension
- Fludrocortisone
- Placebo
-
Paris, FranceHôpital Broca (AP-HP)
Aug 25, 2021
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Prostatic Neoplasms
- MK-5684
- +6 more
- (no location specified)
Nov 21, 2023
Cardiogenic Shock Trial in France (Hydrocortisone + Flucortac, Placebo)
Recruiting
- Cardiogenic Shock
- Hydrocortisone + Flucortac
- Placebo
-
Paris, Ile De France, France
- +20 more
Jun 13, 2022
Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)
Withdrawn
- Congenital Adrenal Hyperplasia
- Abiraterone acetate
- +3 more
-
Los Angeles, California
- +3 more
Jan 30, 2023
Critically Ill, Septic Shock Trial in Australia (Fludrocortisone Acetate, Standard Therapy)
Recruiting
- Critically Ill
- Septic Shock
- Fludrocortisone Acetate
- Standard Therapy
-
Sydney, New South Wales, Australia
- +8 more
Mar 29, 2021
Borderline Personality Disorder Trial in Berlin (Fludrocortisone, Placebo, Trier Social Stress Test (TSST))
Recruiting
- Borderline Personality Disorder
- Fludrocortisone
- +3 more
-
Berlin, GermanyCharite University
Apr 8, 2022
Syncope, Vasovagal Trial in Tehran (Midodrine Hydrochloride Tablets, Fludrocortisone Acetate Tablets, Lifestyle modification)
Recruiting
- Syncope, Vasovagal
- Midodrine Hydrochloride Tablets
- +2 more
-
Tehran, Iran, Islamic Republic ofTehran Heart Center
Apr 14, 2021
Partial Mineralocorticoid Deficiency Trial in Paris (Oral Fludrocortisone (enteral), Placebo Oral Tablet)
Completed
- Partial Mineralocorticoid Deficiency
- Oral Fludrocortisone (enteral)
- Placebo Oral Tablet
-
Paris, FranceHôpital Robert Debré
Feb 15, 2021
Septic Shock Trial in Knoxville (Hydrocortisone)
Completed
- Septic Shock
-
Knoxville, TennesseeUniversity of Tennessee Medical Center
Apr 30, 2021
Autonomic Disturbances in Parkinson's Disease Trial in Zurich (Pyridostigmine bromide, fludrocortisone)
Completed
- Autonomic Disturbances in Parkinson's Disease
- Pyridostigmine bromide
- fludrocortisone
-
Zurich, ZH, SwitzerlandUniversity Hospital Zurich, Division of Neurology
Jan 21, 2021
Clinical Pharmacology Trial in Neuss (Finerenone (BAY 94-8862) PEG solution, Finerenone (BAY 94-8862) immediate release tablet,
Completed
- Clinical Pharmacology
- Finerenone (BAY 94-8862) PEG solution
- +3 more
-
Neuss, Nordrhein-Westfalen, Germany(unnamed)
Jan 27, 2022
Healthy Volunteers Trial in Boston (Placebo, Fludrocortisone, Eplerenone)
Completed
- Healthy Volunteers
- Placebo
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 4, 2021
Seated Saline Suppression Test for Primary Aldosteronism
Completed
- Primary Aldosteronism
- Seated saline infusion test
-
Chongqing, Chongqing, ChinaThe First Affilated Hospital of Chongqing Medical University
Jan 26, 2021
Major Depression Trial in Berlin (Placebo, Fludrocortisone, D-Cycloserine)
Completed
- Major Depression
- Placebo
- +2 more
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Jun 19, 2020
Hearing Loss, Sensorineural Trial in Portland (Fludrocortisone)
Terminated
- Hearing Loss, Sensorineural
- Fludrocortisone
-
Portland, OregonOregon Health & Science University
Oct 15, 2019
Sepsis Trial in Garches (Administration procedures)
Recruiting
- Sepsis
- Administration procedures
-
Garches, Hauts-de-Seine, FranceDepartment of medical and surgical Intensive Care Unit, Raymond
May 12, 2022